Cargando…
Embolia cutis Medicamentosa (Nicolau syndrome): case series
INTRODUCTION: Embolia cutis medicamentosa or Nicolau syndrome is a rare drug reaction associated with the administration of various injectable medications. The pathogenesis of the disease is unknown, though intra and periarterial injection of the drug is a possible cause. The aim of this study was t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653301/ https://www.ncbi.nlm.nih.gov/pubmed/38020151 http://dx.doi.org/10.3389/fmed.2023.1216781 |
_version_ | 1785136382466850816 |
---|---|
author | Fekete, Gyula Laszlo Iantovics, Laszlo Barna Fekete, Júlia Edit Fekete, Laszlo |
author_facet | Fekete, Gyula Laszlo Iantovics, Laszlo Barna Fekete, Júlia Edit Fekete, Laszlo |
author_sort | Fekete, Gyula Laszlo |
collection | PubMed |
description | INTRODUCTION: Embolia cutis medicamentosa or Nicolau syndrome is a rare drug reaction associated with the administration of various injectable medications. The pathogenesis of the disease is unknown, though intra and periarterial injection of the drug is a possible cause. The aim of this study was to describe and analyze the clinical characteristics of Nicolau syndrome in patients examined in daily dermatological practice. METHODS: We performed a retrospective chart review, between January 2011 and December 2020, in patients diagnosed with Nicolau syndrome, from the cases of a private dermatology medical office in Târgu Mureș, Romania. RESULTS: During the 10-year period, 7 patients were diagnosed with Nicolau syndrome. Of these, 4 (57%) patients were males and 3 (43%) were females, The male to female ratio was 1.33. The median age was 64 (interquartile range, IQR, 62–71), with the youngest patient being diagnosed at age 61 and the oldest at age 74. Regarding the drugs classes that caused Nicolau syndrome, these were intravenous antibiotics in 57%, and non-steroidal anti-inflammatory drugs in 43% of cases. CONCLUSION: All patients healed in a period of 6 to 8 weeks. No complications occurred. In conclusion, Nicolau syndrome is a rare side effect of injectable drug administration. |
format | Online Article Text |
id | pubmed-10653301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106533012023-11-02 Embolia cutis Medicamentosa (Nicolau syndrome): case series Fekete, Gyula Laszlo Iantovics, Laszlo Barna Fekete, Júlia Edit Fekete, Laszlo Front Med (Lausanne) Medicine INTRODUCTION: Embolia cutis medicamentosa or Nicolau syndrome is a rare drug reaction associated with the administration of various injectable medications. The pathogenesis of the disease is unknown, though intra and periarterial injection of the drug is a possible cause. The aim of this study was to describe and analyze the clinical characteristics of Nicolau syndrome in patients examined in daily dermatological practice. METHODS: We performed a retrospective chart review, between January 2011 and December 2020, in patients diagnosed with Nicolau syndrome, from the cases of a private dermatology medical office in Târgu Mureș, Romania. RESULTS: During the 10-year period, 7 patients were diagnosed with Nicolau syndrome. Of these, 4 (57%) patients were males and 3 (43%) were females, The male to female ratio was 1.33. The median age was 64 (interquartile range, IQR, 62–71), with the youngest patient being diagnosed at age 61 and the oldest at age 74. Regarding the drugs classes that caused Nicolau syndrome, these were intravenous antibiotics in 57%, and non-steroidal anti-inflammatory drugs in 43% of cases. CONCLUSION: All patients healed in a period of 6 to 8 weeks. No complications occurred. In conclusion, Nicolau syndrome is a rare side effect of injectable drug administration. Frontiers Media S.A. 2023-11-02 /pmc/articles/PMC10653301/ /pubmed/38020151 http://dx.doi.org/10.3389/fmed.2023.1216781 Text en Copyright © 2023 Fekete, Iantovics, Fekete and Fekete. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Fekete, Gyula Laszlo Iantovics, Laszlo Barna Fekete, Júlia Edit Fekete, Laszlo Embolia cutis Medicamentosa (Nicolau syndrome): case series |
title | Embolia cutis Medicamentosa (Nicolau syndrome): case series |
title_full | Embolia cutis Medicamentosa (Nicolau syndrome): case series |
title_fullStr | Embolia cutis Medicamentosa (Nicolau syndrome): case series |
title_full_unstemmed | Embolia cutis Medicamentosa (Nicolau syndrome): case series |
title_short | Embolia cutis Medicamentosa (Nicolau syndrome): case series |
title_sort | embolia cutis medicamentosa (nicolau syndrome): case series |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653301/ https://www.ncbi.nlm.nih.gov/pubmed/38020151 http://dx.doi.org/10.3389/fmed.2023.1216781 |
work_keys_str_mv | AT feketegyulalaszlo emboliacutismedicamentosanicolausyndromecaseseries AT iantovicslaszlobarna emboliacutismedicamentosanicolausyndromecaseseries AT feketejuliaedit emboliacutismedicamentosanicolausyndromecaseseries AT feketelaszlo emboliacutismedicamentosanicolausyndromecaseseries |